Edoxaban versus warfarin in patients with atrial fibrillation

Giugliano, RP; Ruff, CT; Braunwald, E; Murphy, SA; Wiviott, SD; Halperin, JL; Waldo, AL; Ezekowitz, MD; Weitz, JI; Špinar, J; Ruzyllo, W; Ruda, M; Koretsune, Y; Betcher, J; Shi, M; Grip, LT; Patel, SP; Patel, I; Hanyok, JJ; Mercuri, M; Antman, EM; Peruzzotti-Jametti, L; Malynovsky, Y; Morin, SE; Hoffman, EB; Deenadayalu, N; Lanz, H; Curt, V; Duggal, A; Davé, J; Morgan, D; Choi, Y; Jin, J; Xie, J; Crerand, W; Kappelhof, J; Maxwell, W; Skinner, M; Selicato, G; Otto, C; Reissner, C; Smith, K; Ostroske, J; Ron, A; Connolly, S; Camm, J; Paolasso, E; Aylward, P; Heidbuchel, H; Nicolau, JC; Goudev, A; Roy, D; Corbalán, R; Yang, Y; Botero, R; Bergovec, M; Grande, P; Hassager, C; Voitk, J; Huikuri, H; Nieminen, M; Blanc, JJ; LeHeuzey, JY; Mitrovic, V; Alexopoulos, D; Sotomora, G; Kiss, R; SomaRaju, B; Lewis, B; Merlini, P; Metra, M; Yamashita, T; García-Castillo, A; Ophuis, T; White, H; Atar, D; Horna, M; Babilonia, N; Morais, J; Dorobantu, M; Ostojic, M; Duris, T; Dalby, A; Chung, N; Zamorano, JL; Juul-Möller, S; Moccetti, T; Chen, SA; Sritara, P; Oto, A; Parkhomenko, A; Senior, R; Verheugt, F; Skene, A; Anderson, J; Bauer, K; Easton, JD; Goto, S; Lowe, C

Edoxaban versus warfarin in patients with atrial fibrillation

Version 2 2024-06-05, 03:18

Version 1 2022-12-01, 02:53

journal contribution

posted on 2024-06-05, 03:18 authored by RP Giugliano, CT Ruff, E Braunwald, SA Murphy, SD Wiviott, JL Halperin, AL Waldo, MD Ezekowitz, JI Weitz, J Špinar, W Ruzyllo, M Ruda, Y Koretsune, J Betcher, M Shi, LT Grip, SP Patel, I Patel, JJ Hanyok, M Mercuri, EM Antman, L Peruzzotti-Jametti, Y Malynovsky, SE Morin, EB Hoffman, N Deenadayalu, H Lanz, V Curt, A Duggal, J Davé, D Morgan, Y Choi, J Jin, J Xie, W Crerand, J Kappelhof, W Maxwell, M Skinner, G Selicato, C Otto, C Reissner, K Smith, J Ostroske, A Ron, S Connolly, J Camm, E Paolasso, P Aylward, H Heidbuchel, JC Nicolau, A Goudev, D Roy, R Corbalán, Y Yang, R Botero, M Bergovec, P Grande, C Hassager, J Voitk, H Huikuri, M Nieminen, JJ Blanc, JY LeHeuzey, V Mitrovic, D Alexopoulos, G Sotomora, R Kiss, B SomaRaju, B Lewis, P Merlini, M Metra, T Yamashita, A García-Castillo, T Ophuis, H White, D Atar, M Horna, N Babilonia, J Morais, M Dorobantu, M Ostojic, T Duris, A Dalby, N Chung, JL Zamorano, S Juul-Möller, T Moccetti, SA Chen, P Sritara, A Oto, A Parkhomenko, R Senior, F Verheugt, A Skene, J Anderson, K Bauer, JD Easton, S Goto, C Lowe

Edoxaban versus warfarin in patients with atrial fibrillation

History

Journal

New England Journal of Medicine

Volume

369

Pagination

2093-2104

Location

United States

Publisher DOI

https://doi.org/10.1056/NEJMoa1310907

ISSN

0028-4793

eISSN

1533-4406

Language

English

Publication classification

C1.1 Refereed article in a scholarly journal

Issue

22

Publisher

MASSACHUSETTS MEDICAL SOC

Usage metrics

Keywords

Science & Technology Life Sciences & Biomedicine Medicine, General & Internal General & Internal Medicine FACTOR XA INHIBITOR ORAL ANTICOAGULANTS STROKE PHARMACOKINETICS METAANALYSIS GENERATION PREVENTION SAFETY

Licence

Exports

RefWorks

BibTeX

Ref. manager

Endnote

DataCite

NLM

DC

Edoxaban versus warfarin in patients with atrial fibrillation

History

Journal

Volume

Pagination

Location

Publisher DOI

ISSN

eISSN

Language

Publication classification

Issue

Publisher

Usage metrics

Categories

Keywords

Licence

Exports